Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease

Dermatology Online Journal

Volumn 16, Issue 9, 2010, Pages

  Beccastrini, E ^a   Squatrito, D ^a   Emmi, G ^a   Fabbri, P ^a   Emmi, L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; HLA B51 ANTIGEN; INFLIXIMAB; MINOXIDIL; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ADULT; ALLELE; ALOPECIA AREATA; BEHCET DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG WITHDRAWAL; EYE DISEASE; EYE MOVEMENT; HUMAN; KNEE ARTHRITIS; LETTER; MALE; NAIL DISEASE; NAIL DYSTROPHY; OFF LABEL DRUG USE; OROGENITAL ULCER; RELAPSE; ULCER; UVEITIS; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; IMMUNOLOGY;

ADULT; ALOPECIA AREATA; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; AUTOIMMUNE DISEASES; BEHCET SYNDROME; HUMANS; MALE; OFF-LABEL USE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958120026     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Letter

References (11)

1. Ferran M, Calvet J, Almiral M, Pujol RM, Maymó J. Alopecia Areata as another immune-mediated disease developed in patients treated with tumour necrosis factor-α blocker agents. J Eur Acad Dermatol Venereol 2010 Jun; 24 [Epub ahead of print]. [PubMed]
2. Ettefagh L, Nedorost L, Mirmirani P. Alopecia areata in a patient using Infliximab: new insights into the role of Tumor necrosis factor on human hair follicles. Arch Dermatol 2004 Aug; 140(8):101. [PubMed]
3. Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G. Alopecia areata during treatment with biologic agents. Arch Dermatol 2006 Dec; 142(12):1653-4. [PubMed]
4. Nakagomi D, Harada K, Yagasaki A, Kawamura T, Shibagaki N, Shimada S. Psoriasiform eruption associated with alopecia areata during Infliximab therapy. Clin Exp Dermatol 2009 Dec; 34(8):923-4. [PubMed]
5. Fabre C, Dereure O. Worsening of alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab. Dermatology 2008; 216(2):185-6. [PubMed]
6. Medkour F, Babai S, Chanteloup E, Buffard V, Delchier JC, Le-Louet H. Development of diffuse psoriasis with alopecia during treatment of Chron's disease with Infliximab. Gastroenterol Clin Biol 2010 Feb; 34(2):140-1. [PubMed]
7. Hernàndez MV, Noguès S, Ruiz-Esquide V, Alsina M, Cañete JD, Sanmartí R. Development of alopecia areata after biological therapy with TNF-alpha blockers: description of a case and review of the literature. Clin Exp Rheumatol 2009 Sep-Oct; 27(5):892-3. [PubMed]
8. Katagiri K, Arakawa S, Hatano Y. In vivo levels of IL-4, IL-10, TGF-β1 and IFN-γ mRNA of the peripheral blood mononuclear cells in patients with alopecia areata in comparison to those in patients with atopic dermatitis. Arch Dermatol Res 2007 Jan; 298(8):397-401. [PubMed]
9. Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R. Cytokines and growth factors influence hair growth in vitro. Possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res 1996 Mar; 288(3):153-6. [PubMed]
10. Strober BE, Siu K, Alexis AF, Kim G, Washenik K, Sinha A, Shupack JL. Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study. J Am Acad Dermatol 2005 Jun; 52(6):1082-4. [PubMed]
11. De Bandt M, Sibilia J, Le Loët X, Prouzeau S, Fautrel B, Marcelli C, Boucquillard E, Siame JL, Mariette X; Club Rhumatismes et Inflammation. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 2005; 7(3):R545-51. [PubMed]